Cargando…
Hypercoagulability Evaluation in Antiphospholipid Syndrome without Anticoagulation Treatment with Thrombin Generation Assay: A Preliminary Study
Antiphospholipid syndrome (APS) is associated with thrombotic events (tAPS) and/or obstetrical morbidity (oAPS), with persisting antiphospholipid antibodies (aPL). Despite an update of aPL in 2006, several patients had typical clinical events without the classical biological criteria. The aim of our...
Autores principales: | Billoir, Paul, Miranda, Sébastien, Levesque, Herve, Benhamou, Ygal, Le Cam Duchez, Véronique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234883/ https://www.ncbi.nlm.nih.gov/pubmed/34205545 http://dx.doi.org/10.3390/jcm10122728 |
Ejemplares similares
-
Investigation of thrombin generation assay to predict vaso-occlusive crisis in adulthood with sickle cell disease
por: Feugray, Guillaume, et al.
Publicado: (2022) -
Hydroxychloroquine reverses the prothrombotic state in a mouse model of antiphospholipid syndrome: Role of reduced inflammation and endothelial dysfunction
por: Miranda, Sébastien, et al.
Publicado: (2019) -
Anticoagulation Monitoring with Activated Partial ThromboPlastin Time and Anti-Xa Activity in Intensive Care Unit Patients: Interest of Thrombin Generation Assay
por: Billoir, Paul, et al.
Publicado: (2022) -
Thrombin Generation Assay Detects Moderate-Intensity Statin-Induced Reduction of Hypercoagulability in Diabetes
por: Park, Hee Sue, et al.
Publicado: (2018) -
Assessment of Reticulocyte and Erythrocyte Parameters From Automated Blood Counts in Vaso-Occlusive Crisis on Sickle Cell Disease
por: Feugray, Guillaume, et al.
Publicado: (2022)